A Structured Protocol to Optimize Proton Pump Inhibitor Use: A Quality Improvement Initiative
1Shiny Edward is the clinical excellence program director at Texas Health Arlington Memorial Hospital, Arlington, Texas.
Background:
Proton pump inhibitors are widely used to treat gastrointestinal conditions, but prolonged use increases the risk of infections, fractures, kidney disease, and other adverse outcomes, particularly in adults aged 65 years and older. Despite guideline recommendations for limited duration, inappropriate prescribing remains common, contributing to adverse outcomes and increased health care costs.
Local Problem:
Baseline audits at a 24-bed telemetry unit in a Texas community hospital revealed that 35.3% of older adults were prescribed proton pump inhibitors without appropriate indication. The purpose of this initiative was to evaluate the effect of a nurse-led proton pump inhibitor medication review using a structured proton pump inhibitor deprescribing algorithm.
Methods:
This 16-week quality improvement initiative, guided by the Iowa Model of Evidence-Based Practice, included an 8-week preimplementation phase followed by an 8-week postimplementation assessment phase. Forty-five nurses were trained to apply the deprescribing algorithm in collaboration with physicians and pharmacists at patient admission and discharge. Implementation tools included electronic health record text templates, patient education resources, and interprofessional huddles.
Results:
Among 186 patient records reviewed, inappropriate proton pump inhibitor use declined from 35% to 5% (P < .001). No adverse gastrointestinal events were reported. Informal feedback showed increased nurse confidence in and knowledge of deprescribing practices.
Conclusions:
This nurse-led intervention significantly reduced inappropriate proton pump inhibitor prescriptions and enhanced patient safety. Integration of decision tools, education, and interprofessional collaboration supported sustainability. The model is scalable to other medication stewardship efforts in acute care.
More Related Videos
Related Concept Videos
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Drug Elimination by Renal Route: Tubular Secretion
Dosage Regimens: Designs and Approaches
Dosage Regimens: Partial Pharmacokinetic Parameters
Pore Transport and Ion-Pair Transport
Pore transport, also known as convective transport, is a process where small molecules like urea, water, and sugars rapidly cross cell membranes as though there were channels or pores in the membrane. Although direct microscopic evidence is limited but the concept of pores or channels is widely accepted based on physiological evidence. Despite the lack of direct...


